Synthesis and Spectral Characterization of 4,7-Dichloro-6-nitroquinazoline
Afatinib is a 4-anilinoquinazoline tyrosine kinase inhibitor (TKI) in the form of a dimaleate salt which is indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC). The most scalable route for the synthesis of this drug was reported in two Boehringer Ingelhei...
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
MDPI AG
2020-05-01
|
| Series: | Molbank |
| Subjects: | |
| Acceso en liña: | https://www.mdpi.com/1422-8599/2020/2/M1134 |